ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
1,2,Haemoglobinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1,3,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
2,1,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
2,2,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
2,3,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
2,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
5,1,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
6,1,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
7,1,Idiopathic pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
8,1,Erythema induratum,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
8,2,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
9,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
9,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
10,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
10,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
11,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
11,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
12,1,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
13,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
14,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
15,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
16,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
16,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
16,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
17,1,Coombs positive haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,Y
18,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
19,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
19,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
19,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
19,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
20,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
21,1,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
22,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
22,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
22,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
23,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,Y
24,1,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,Y
25,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
26,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
26,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
26,3,Headache,Headaches NEC,Headaches,Nerv,N
26,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
27,1,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
27,2,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
28,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
28,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
28,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
28,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
29,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
30,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
30,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
30,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
31,1,Glomerulonephritis membranoproliferative,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
31,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
32,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
33,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
33,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
33,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
33,4,Hypertonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
34,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
34,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
34,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
34,4,Hyperpyrexia,Febrile disorders,Body temperature conditions,Genrl,N
34,5,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
34,6,Visual field defect,Visual field disorders,Vision disorders,Eye,N
35,1,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
36,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
36,2,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
36,3,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
36,4,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
36,5,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
36,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
37,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
38,1,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
38,2,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
39,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
39,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
39,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
39,4,Headache,Headaches NEC,Headaches,Nerv,N
39,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
39,6,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
39,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
39,8,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
40,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
41,1,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
42,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
43,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
44,1,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,Y
45,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
46,1,Duodenal ulcer perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
46,2,Mycobacterial infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
47,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,Y
48,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,Y
49,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
50,1,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
51,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
52,1,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,Y
53,1,Cerebral toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,Y
54,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
55,1,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
55,2,Thrombotic thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,N
56,1,Seborrhoeic dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
57,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
57,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
58,1,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
58,2,Gingivitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
58,3,Intestinal infarction,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
59,1,Macular degeneration,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
60,1,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,Y
61,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
61,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
62,1,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
63,1,Megakaryocytes decreased,Bone marrow and immune tissue histopathology procedures,Haematology investigations (incl blood groups),Inv,Y
64,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
64,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
65,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
65,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
65,3,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
65,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
65,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
66,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
66,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
66,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
66,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
67,1,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
68,1,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
69,1,Erythropenia,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
69,2,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
70,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
70,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
70,3,Transfusion,Blood and blood product treatment,Haematological and lymphoid tissue therapeutic procedures,Surg,N
71,1,Pityriasis rubra pilaris,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
72,1,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
73,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
73,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
73,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
74,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
75,1,Infectious mononucleosis,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
75,2,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
76,1,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
77,1,Erythema nodosum,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
77,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
77,3,Labyrinthitis,Ear infections,Infections - pathogen unspecified,Infec,N
77,4,Skin induration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
78,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
78,2,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
78,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
78,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
79,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
79,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
80,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
80,2,Deafness,Hearing losses,Hearing disorders,Ear,N
80,3,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
80,4,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
80,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
80,6,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
80,7,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
80,8,Optic atrophy,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
80,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
81,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
81,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
82,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
82,2,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
83,1,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,Y
84,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
84,2,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
84,3,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
84,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
85,1,Pemphigus,Bullous conditions,Epidermal and dermal conditions,Skin,Y
86,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
86,2,Candida sepsis,Candida infections,Fungal infectious disorders,Infec,Y
86,3,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
86,4,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
86,5,Onycholysis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
86,6,Pemphigus,Bullous conditions,Epidermal and dermal conditions,Skin,N
86,7,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
86,8,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
87,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
87,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
88,1,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
89,1,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
89,2,Viraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
90,1,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,N
90,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
90,3,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
91,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,Y
91,2,Pneumonia fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
91,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
91,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
92,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
93,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,Y
94,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
94,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
95,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
96,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
97,1,Pemphigus,Bullous conditions,Epidermal and dermal conditions,Skin,N
98,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
98,2,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,Y
99,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
100,1,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,N
100,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
101,1,Anaemia macrocytic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
102,1,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
103,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
103,2,Change of bowel habit,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
103,3,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
103,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
104,1,Pemphigus,Bullous conditions,Epidermal and dermal conditions,Skin,N
105,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
106,1,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,Y
106,2,Upper respiratory tract inflammation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
107,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
108,1,Pleuritic pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
108,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
109,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
110,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
111,1,Eye infection fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
111,2,Immunodeficiency,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
111,3,Keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
112,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
113,1,Anuria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
113,2,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
113,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
114,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
115,1,Encephalitis herpes,Herpes viral infections,Viral infectious disorders,Infec,N
115,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
115,3,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
116,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
116,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
117,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
117,2,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
117,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
118,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
118,2,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
118,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
119,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,Y
119,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
119,3,Hepatitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
120,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,Y
120,2,Hepatitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
121,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
121,2,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
121,3,Hepatitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
121,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
121,5,Pneumonia viral,Viral infections NEC,Viral infectious disorders,Infec,N
122,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,Y
122,2,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
122,3,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
122,4,Hepatitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
123,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
123,2,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
124,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
124,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
125,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
125,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
126,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
126,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
126,3,Pneumonia viral,Viral infections NEC,Viral infectious disorders,Infec,N
127,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
128,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
129,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
130,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
131,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
132,1,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
133,1,Angiocentric lymphoma,Angiocentric lymphomas,Lymphomas non-Hodgkin's T-cell,Neopl,N
133,2,Cutaneous T-cell lymphoma,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
134,1,Meningitis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,Y
135,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,Y
135,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
135,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
135,4,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
136,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
136,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
136,3,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
136,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
137,1,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
138,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
139,1,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
140,1,Coombs positive haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
141,1,Alveolar proteinosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
141,2,Cardiac tamponade,Pericardial disorders NEC,Pericardial disorders,Card,N
141,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
141,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
141,5,Parainfluenzae virus infection,Parainfluenzae viral infections,Viral infectious disorders,Infec,N
141,6,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,Y
141,7,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
141,8,Pneumonia fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
141,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
142,1,Lichen planus,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
143,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
143,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
143,3,Myelitis transverse,Myelitis (incl infective),Central nervous system infections and inflammations,Nerv,Y
143,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
144,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
144,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
145,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
145,2,Parapsoriasis,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
145,3,Seborrhoeic keratosis,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
145,4,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
146,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
147,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
147,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
148,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
148,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
149,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
150,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
150,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
151,1,Headache,Headaches NEC,Headaches,Nerv,N
152,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
152,2,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
152,3,Ophthalmic herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
153,1,Megakaryocytes decreased,Bone marrow and immune tissue histopathology procedures,Haematology investigations (incl blood groups),Inv,N
154,1,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
155,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
156,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
157,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
157,2,Vitritis,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
158,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
158,2,Coma,Coma states,Neurological disorders NEC,Nerv,N
158,3,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,Y
158,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
159,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
159,2,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
160,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
161,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
162,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,Y
163,1,Richter's syndrome,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
164,1,Epstein-Barr virus antigen positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
164,2,Richter's syndrome,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
165,1,Richter's syndrome,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
166,1,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
167,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
167,2,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
167,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
167,4,Marrow hyperplasia,Haematologic neoplasms NEC,Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
168,1,Richter's syndrome,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
169,1,Epstein-Barr virus antigen positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
169,2,Richter's syndrome,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
170,1,Richter's syndrome,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
171,1,Richter's syndrome,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
172,1,Richter's syndrome,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
173,1,Chronic lymphocytic leukaemia transformation,Leukaemias chronic lymphocytic,Leukaemias,Neopl,N
173,2,Richter's syndrome,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
174,1,Richter's syndrome,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
175,1,Epstein-Barr virus antigen positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
175,2,Richter's syndrome,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
176,1,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
177,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
177,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
178,1,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
179,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
179,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
179,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
179,4,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
179,5,Marrow hyperplasia,Haematologic neoplasms NEC,Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
180,1,Hepatosplenomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
180,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
180,3,Pneumonia legionella,Legionella infections,Bacterial infectious disorders,Infec,Y
181,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
182,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
183,1,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
183,2,Hepatorenal failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
183,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
184,1,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
184,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
185,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
185,2,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
185,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
186,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
187,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
187,2,Hepatitis B reactivation,Hepatitis virus infections,Viral infectious disorders,Infec,N
187,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
187,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
188,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
189,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
189,2,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
189,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
190,1,Coombs positive haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
191,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
192,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
192,2,Pulmonary function test decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
193,1,Amaurosis,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
193,2,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
194,1,Paraneoplastic pemphigus,Bullous conditions,Epidermal and dermal conditions,Skin,N
194,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
194,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
195,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
196,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,Y
196,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
197,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
198,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
199,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
200,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
201,1,Intestinal pseudo-obstruction,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
202,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
203,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
203,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
204,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
205,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
206,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
206,2,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
206,3,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
206,4,Vitritis,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
207,1,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
208,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
208,2,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
209,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
210,1,Meningitis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
211,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
212,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
212,2,Hypovolaemic shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
212,3,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
212,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
213,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
213,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
213,3,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
213,4,Factor VIII inhibition,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
214,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
214,2,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
214,3,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,Y
215,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
215,2,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
215,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
216,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
216,2,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
217,1,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
217,2,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
217,3,Lymphoma transformation,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,Y
217,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
218,1,Auricular swelling,External ear disorders NEC,External ear disorders (excl congenital),Ear,N
218,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
218,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
218,4,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
219,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
219,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
219,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
220,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,Y
220,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
221,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
221,2,Herpes virus infection,Herpes viral infections,Viral infectious disorders,Infec,Y
222,1,Richter's syndrome,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
223,1,Alveolitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
224,1,Chronic lymphocytic leukaemia transformation,Leukaemias chronic lymphocytic,Leukaemias,Neopl,N
224,2,Hepatorenal failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
224,3,T-cell lymphoma,Anaplastic large cell lymphomas T- and null-cell types,Lymphomas non-Hodgkin's T-cell,Neopl,N
225,1,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
226,1,Lhermitte's sign,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
226,2,Myelopathy,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
227,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
228,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
228,2,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
228,3,Orbital haemorrhage,Ocular bleeding and vascular disorders NEC,Ocular haemorrhages and vascular disorders NEC,Eye,N
229,1,Candida pneumonia,Candida infections,Fungal infectious disorders,Infec,N
229,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,Y
229,3,Pneumonia viral,Viral infections NEC,Viral infectious disorders,Infec,N
230,1,Myelodysplastic syndrome with single lineage dysplasia,Myelodysplastic syndromes,Leukaemias,Neopl,N
231,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
231,2,Myelodysplastic syndrome with single lineage dysplasia,Myelodysplastic syndromes,Leukaemias,Neopl,Y
232,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
233,1,Myelodysplastic syndrome with excess blasts,Myelodysplastic syndromes,Leukaemias,Neopl,Y
234,1,Myelodysplastic syndrome with single lineage dysplasia,Myelodysplastic syndromes,Leukaemias,Neopl,N
235,1,Myelodysplastic syndrome with single lineage dysplasia,Myelodysplastic syndromes,Leukaemias,Neopl,Y
236,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
237,1,Hypersensitivity pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
237,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
238,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
239,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
239,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
239,3,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
239,4,Dysgraphia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
239,5,Neurological decompensation,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
239,6,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
240,1,Congenital aplasia,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
240,2,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
241,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
242,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
242,2,Hepatitis B,Hepatitis virus infections,Viral infectious disorders,Infec,N
243,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
243,2,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
243,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
244,1,Coombs negative haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
245,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
246,1,Cerebral toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,N
246,2,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
246,3,Leukaemia recurrent,Leukaemias NEC,Leukaemias,Neopl,Y
247,1,Autoimmune neutropenia,Neutropenias,White blood cell disorders,Blood,N
247,2,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
247,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
247,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
248,1,Autoimmune neutropenia,Neutropenias,White blood cell disorders,Blood,N
249,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
249,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
249,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
249,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
250,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
251,1,Bronchiolitis,Viral infections NEC,Viral infectious disorders,Infec,N
251,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
251,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
251,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
252,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
253,1,Angiotensin converting enzyme decreased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
253,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
253,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
253,4,Fibrosis,Fibrosis NEC,Tissue disorders NEC,Genrl,N
253,5,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
253,6,Granuloma skin,Granulomatous and deep cutaneous inflammatory conditions,Epidermal and dermal conditions,Skin,N
253,7,Granulomatous liver disease,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
253,8,Liver palpable,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
253,9,Oral disorder,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
253,10,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
253,11,Sarcoidosis,Acute and chronic sarcoidosis,Immune disorders NEC,Immun,N
253,12,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
254,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
254,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
254,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
254,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
255,1,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
256,1,Petit mal epilepsy,Absence seizures,Seizures (incl subtypes),Nerv,N
257,1,Acute graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
257,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
257,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
257,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
257,5,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
257,6,Toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,N
257,7,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
258,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
258,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
258,3,Pulmonary toxicity,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
259,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
260,1,Granulocytes maturation arrest,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
260,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
260,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
260,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
261,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
262,1,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
262,2,Gastroenteritis cryptosporidial,Cryptosporidia infections,Protozoal infectious disorders,Infec,N
262,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
262,4,Pneumococcal sepsis,Streptococcal infections,Bacterial infectious disorders,Infec,N
263,1,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
264,1,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
264,2,Retinitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
265,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
265,2,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
266,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
266,2,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
267,1,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
267,2,Pneumonia fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
267,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
267,4,Viraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
268,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
269,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
269,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
270,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
270,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
271,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
271,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
271,3,Pharyngeal ulceration,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
271,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
272,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
273,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
273,2,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
273,3,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
273,4,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
273,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
273,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
274,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
274,2,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
274,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
274,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
274,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
274,6,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,Y
274,7,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
274,8,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
274,9,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
274,10,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
274,11,Upper motor neurone lesion,Motor neurone diseases,Neuromuscular disorders,Nerv,N
274,12,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
275,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
275,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
275,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
276,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
276,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
277,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
277,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
277,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
278,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
278,2,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
279,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
279,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
280,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
280,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
280,3,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
280,4,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
280,5,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
280,6,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
280,7,Idiopathic pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
280,8,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
280,9,Nodular regenerative hyperplasia,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
280,10,Obliterative bronchiolitis,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
280,11,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
280,12,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
280,13,Portal hypertension,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
280,14,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
280,15,Varices oesophageal,Oesophageal varices,Gastrointestinal vascular conditions,Gastr,N
280,16,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
281,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
281,2,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
281,3,Optic atrophy,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
281,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
281,5,Retinitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
282,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
283,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
283,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
284,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
285,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
285,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
285,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
285,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
285,5,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
285,6,Respiratory rate decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
286,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
286,2,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
286,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
287,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
287,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
287,3,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
287,4,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
287,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
288,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
288,2,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
288,3,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
289,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
289,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
289,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
289,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
289,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
290,1,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
291,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
291,2,Sinusitis fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
291,3,VIth nerve paralysis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
292,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
292,2,Sinusitis fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
293,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
293,2,Sinusitis fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
294,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
294,2,Sinusitis fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
295,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
295,2,Sinusitis fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
296,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
296,2,Sinusitis fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
297,1,Prostate cancer recurrent,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
298,1,Listeria sepsis,Listeria infections,Bacterial infectious disorders,Infec,Y
298,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
299,1,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
299,2,Muscle contractions involuntary,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
299,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
299,4,Neuropathic muscular atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
299,5,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
300,1,Autoimmune neutropenia,Neutropenias,White blood cell disorders,Blood,N
301,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
301,2,Metastatic squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
302,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
302,2,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
302,3,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
302,4,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
303,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
303,2,Granular cell tumour,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
303,3,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
303,4,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,Y
304,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
304,2,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
304,3,Metastatic malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
305,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
306,1,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
307,1,Acute abdomen,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
307,2,CSF test abnormal,Cerebrospinal fluid tests (excl microbiology),"Neurological, special senses and psychiatric investigations",Inv,N
307,3,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
307,4,Ileus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
307,5,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
307,6,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
307,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
307,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
307,9,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
307,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
308,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
308,2,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
308,3,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
308,4,Encephalitis cytomegalovirus,Cytomegaloviral infections,Viral infectious disorders,Infec,Y
308,5,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
308,6,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
308,7,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
308,8,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,N
308,9,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
309,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
309,2,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
309,3,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
309,4,Inflammation,Inflammations,General system disorders NEC,Genrl,N
309,5,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
309,6,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
309,7,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
309,8,Oesophageal ulcer,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
309,9,Otitis externa,Ear infections,Infections - pathogen unspecified,Infec,N
309,10,Pneumonia fungal,Fungal infections NEC,Fungal infectious disorders,Infec,Y
309,11,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
309,12,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
310,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
310,2,Opportunistic infection,Infections NEC,Infections - pathogen unspecified,Infec,N
311,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
311,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
311,3,Metastatic squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
311,4,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
312,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
312,2,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
312,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
312,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
313,1,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
313,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
313,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
313,4,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
313,5,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
314,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
314,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
314,3,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
314,4,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
314,5,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
314,6,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
314,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
314,8,Sinus congestion,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
315,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
315,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
315,3,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
315,4,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
315,5,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
315,6,Obstructive airways disorder,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
315,7,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
315,8,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
315,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
315,10,Sinus congestion,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
316,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
316,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
316,3,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,Y
317,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
317,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
318,1,Acute graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
318,2,Adenoviral hepatitis,Adenoviral infections,Viral infectious disorders,Infec,Y
318,3,Evans syndrome,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
319,1,Evans syndrome,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,Y
320,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
320,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
321,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
321,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
321,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
321,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
321,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
322,1,Central nervous system infection,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
322,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
322,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
323,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
324,1,Acute graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
324,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
324,3,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
325,1,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
326,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
326,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
326,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
326,4,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
326,5,Mycobacterium kansasii infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
326,6,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
326,7,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
326,8,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
327,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
327,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
327,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
328,1,Acute graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
328,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
329,1,Chronic graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
329,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
330,1,Cold type haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
331,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
332,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
332,2,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
333,1,Non-Hodgkin's lymphoma unspecified histology aggressive,Non-Hodgkin's lymphomas unspecified histology aggressive,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
334,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
334,2,Autoimmune neutropenia,Neutropenias,White blood cell disorders,Blood,N
334,3,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
334,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
335,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
335,2,Cerebral toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,Y
335,3,Citrobacter sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
335,4,Gangrene,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
335,5,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
335,6,Molluscum contagiosum,Molluscum contagiosum viral infections,Viral infectious disorders,Infec,N
335,7,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
335,8,Pseudomonal sepsis,Pseudomonal infections,Bacterial infectious disorders,Infec,N
335,9,Streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
336,1,Central nervous system infection,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
336,2,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
337,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
338,1,Central nervous system infection,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
338,2,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
338,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
339,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
339,2,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
339,3,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
339,4,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
339,5,Gastroenteritis adenovirus,Adenoviral infections,Viral infectious disorders,Infec,N
339,6,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
339,7,Parvovirus infection,Parvoviral infections,Viral infectious disorders,Infec,N
339,8,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
339,9,Viral myocarditis,Viral infections NEC,Viral infectious disorders,Infec,N
340,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
340,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
340,3,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
340,4,Pulmonary toxicity,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
341,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
341,2,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
342,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
343,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
344,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
344,2,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
344,3,Intravascular haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
344,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
345,1,Debridement,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
345,2,Neoplasm skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
345,3,Oesophageal squamous cell carcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
345,4,Oesophagectomy,Oesophageal therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
345,5,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
345,6,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
345,7,Skin lesion removal,Skin lesion excisions,Skin and subcutaneous tissue therapeutic procedures,Surg,N
345,8,Sweat gland tumour,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
345,9,Sweat gland tumour,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
346,1,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
347,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
347,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
347,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
348,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
348,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
348,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
349,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
349,2,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
349,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
349,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
350,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
350,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
350,3,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,Y
350,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
350,5,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
350,6,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
350,7,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
351,1,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
351,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
351,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
351,4,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
351,5,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
352,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
352,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
352,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
353,1,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
354,1,Autoimmune neutropenia,Neutropenias,White blood cell disorders,Blood,N
355,1,Autoimmune neutropenia,Neutropenias,White blood cell disorders,Blood,N
355,2,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
355,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
355,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
356,1,Angiotensin converting enzyme increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
356,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
356,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
356,4,Fibrosis,Fibrosis NEC,Tissue disorders NEC,Genrl,N
356,5,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
356,6,Granuloma,Inflammations,General system disorders NEC,Genrl,N
356,7,Hepatic iron overload,Hepatic metabolic disorders,Hepatic and hepatobiliary disorders,Hepat,N
356,8,Sarcoidosis,Acute and chronic sarcoidosis,Immune disorders NEC,Immun,N
357,1,Megakaryocytes abnormal,Bone marrow and immune tissue histopathology procedures,Haematology investigations (incl blood groups),Inv,N
357,2,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
358,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
358,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
358,3,Drop attacks,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
358,4,Vestibular disorder,Inner ear disorders NEC,Inner ear and VIIIth cranial nerve disorders,Ear,N
359,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
359,2,Klebsiella sepsis,Klebsiella infections,Bacterial infectious disorders,Infec,N
360,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
360,2,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
360,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
361,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
362,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
363,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
364,1,Central nervous system lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
364,2,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
364,3,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
364,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
364,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
365,1,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
365,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
366,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
367,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
367,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
368,1,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
369,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
369,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
370,1,Hypertonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
370,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
370,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
371,1,Osteomyelitis fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
372,1,H1N1 influenza,Influenza viral infections,Viral infectious disorders,Infec,N
373,1,Congenital aplasia,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
373,2,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
373,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
373,4,Pneumonia fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
373,5,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
374,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
375,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
376,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
376,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
377,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
377,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
377,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
378,1,Fungal sepsis,Fungal infections NEC,Fungal infectious disorders,Infec,Y
379,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
379,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
379,3,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
379,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
380,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
381,1,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
381,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
382,1,Perineal ulceration,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
382,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
383,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
384,1,Autoimmune pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
384,2,Chronic lymphocytic leukaemia,Leukaemias chronic lymphocytic,Leukaemias,Neopl,Y
384,3,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
384,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
384,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
385,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
386,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
387,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
387,2,Systemic candida,Candida infections,Fungal infectious disorders,Infec,Y
388,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
388,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
388,3,Systemic candida,Candida infections,Fungal infectious disorders,Infec,N
389,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
389,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
390,1,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
390,2,Human herpesvirus 6 infection reactivation,Herpes viral infections,Viral infectious disorders,Infec,N
391,1,Polyomavirus-associated nephropathy,Polyomavirus infections,Viral infectious disorders,Infec,N
392,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
392,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
392,3,Kidney fibrosis,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
392,4,Polyomavirus-associated nephropathy,Polyomavirus infections,Viral infectious disorders,Infec,N
392,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
392,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
393,1,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
394,1,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
395,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
396,1,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
397,1,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
398,1,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
399,1,Mononeuropathy multiplex,Mononeuropathies,Peripheral neuropathies,Nerv,N
400,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
400,2,Mononeuropathy multiplex,Mononeuropathies,Peripheral neuropathies,Nerv,N
401,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
401,2,Fungal endocarditis,Fungal infections NEC,Fungal infectious disorders,Infec,N
401,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
401,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
402,1,Cytomegalovirus oesophagitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
402,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
402,3,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
402,4,Oesophageal ulcer,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
402,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
402,6,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
403,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
403,2,Fungal endocarditis,Fungal infections NEC,Fungal infectious disorders,Infec,N
403,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
403,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
404,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
405,1,Abdominal lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
405,2,Cytomegalovirus oesophagitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
405,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
405,4,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
405,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
405,6,Retroperitoneal lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
405,7,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
406,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
406,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
407,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
408,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
409,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
409,2,Stress cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
410,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
411,1,Exfoliative rash,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
412,1,Gene mutation,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
412,2,Large granular lymphocytosis,Leukaemias chronic T-cell,Leukaemias,Neopl,Y
412,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
413,1,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
414,1,Chronic lymphocytic leukaemia recurrent,Leukaemias chronic lymphocytic,Leukaemias,Neopl,N
414,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
415,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
415,2,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
415,3,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
415,4,Death,Death and sudden death,Fatal outcomes,Genrl,Y
415,5,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
415,6,Monocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
415,7,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
415,8,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
415,9,Neutrophilia,Leukocytoses NEC,White blood cell disorders,Blood,N
416,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
416,2,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,Y
417,1,Aura,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
417,2,Focal dyscognitive seizures,Partial complex seizures,Seizures (incl subtypes),Nerv,N
417,3,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
418,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
418,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
419,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
419,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
420,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
421,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
422,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
422,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
422,3,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
423,1,Aura,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
423,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
423,3,Focal dyscognitive seizures,Partial complex seizures,Seizures (incl subtypes),Nerv,N
423,4,JC polyomavirus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
423,5,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
424,1,Bacterial sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
424,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
424,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
424,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
424,5,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,Y
425,1,Injection site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
426,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
426,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
427,1,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
428,1,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
429,1,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
430,1,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
431,1,Blood fibrinogen decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
431,2,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
431,3,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
431,4,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
431,5,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
431,6,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
431,7,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
431,8,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
431,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
431,10,Serum ferritin increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
432,1,Blood fibrinogen decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
432,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
432,3,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
432,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
432,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
432,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
432,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
432,8,Serum ferritin increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
432,9,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
433,1,Blood fibrinogen decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
433,2,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
433,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
433,4,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
433,5,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
433,6,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
433,7,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
433,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
433,9,Serum ferritin increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
433,10,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
434,1,Blood fibrinogen decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
434,2,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
434,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
434,4,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
434,5,Human herpesvirus 6 infection reactivation,Herpes viral infections,Viral infectious disorders,Infec,N
434,6,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
434,7,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
434,8,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
434,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
434,10,Serum ferritin increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
434,11,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
435,1,Blood fibrinogen decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
435,2,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
435,3,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
435,4,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
435,5,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
435,6,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
435,7,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
435,8,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
435,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
435,10,Serum ferritin increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
435,11,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
436,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
436,2,Blood fibrinogen decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
436,3,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
436,4,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
436,5,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
436,6,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
436,7,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
436,8,Parvovirus infection,Parvoviral infections,Viral infectious disorders,Infec,N
436,9,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
436,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
436,11,Serum ferritin increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
436,12,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
437,1,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
438,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
439,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
439,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
439,3,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
440,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
441,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
442,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
442,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
443,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
443,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
443,3,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
443,4,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
443,5,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
443,6,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
443,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
443,8,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
444,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
444,2,Chronic lymphocytic leukaemia,Leukaemias chronic lymphocytic,Leukaemias,Neopl,N
444,3,Chronic lymphocytic leukaemia recurrent,Leukaemias chronic lymphocytic,Leukaemias,Neopl,N
444,4,Death,Death and sudden death,Fatal outcomes,Genrl,Y
444,5,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
444,6,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
444,7,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
444,8,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
444,9,Papilloma viral infection,Papilloma viral infections,Viral infectious disorders,Infec,N
444,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
444,11,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
445,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
445,2,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
445,3,Lower respiratory tract infection viral,Viral infections NEC,Viral infectious disorders,Infec,N
445,4,Pulmonary arterial hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
446,1,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
447,1,Blood stem cell transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
447,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
448,1,Blood stem cell transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
449,1,Blood stem cell transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
450,1,Blood stem cell transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
451,1,Disseminated Bacillus Calmette-Guerin infection,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
451,2,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
451,3,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
451,4,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
452,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
452,2,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,N
452,3,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
453,1,Chronic graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
453,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
453,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
454,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
455,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
455,2,Leukaemia recurrent,Leukaemias NEC,Leukaemias,Neopl,N
456,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
456,2,Premature menopause,Menopausal effects NEC,Menopause related conditions,Repro,N
457,1,Acute febrile neutrophilic dermatosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
458,1,Acute febrile neutrophilic dermatosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
459,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
460,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
461,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
462,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
463,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
463,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
463,3,Delirium,Deliria,Deliria (incl confusion),Psych,N
463,4,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
463,5,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
463,6,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
464,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
464,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
464,3,Delirium,Deliria,Deliria (incl confusion),Psych,N
465,1,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
466,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
467,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
468,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
468,2,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
469,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
469,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
469,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
469,4,Streptococcal bacteraemia,Streptococcal infections,Bacterial infectious disorders,Infec,N
469,5,Viral test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
470,1,Blindness cortical,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
470,2,Toxic optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
471,1,Capillary leak syndrome,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
471,2,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
471,3,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
471,4,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
471,5,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
471,6,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
472,1,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,Y
473,1,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,Y
474,1,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,Y
475,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
475,2,Disseminated varicella zoster vaccine virus infection,Herpes viral infections,Viral infectious disorders,Infec,Y
475,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
476,1,Acute lymphocytic leukaemia recurrent,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
477,1,Acute lymphocytic leukaemia recurrent,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
478,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,Y
478,2,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
478,3,Bacterial sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
478,4,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
478,5,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
478,6,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
479,1,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,Y
479,2,Locked-in syndrome,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
479,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
479,4,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
479,5,Spinal cord injury,Spinal cord injuries NEC,Injuries NEC,Inj&P,N
480,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
480,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
480,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
480,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
480,5,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
481,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
481,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
481,3,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
482,1,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
483,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
483,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
483,3,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
484,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
484,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
484,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
484,4,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
485,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
485,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
485,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
485,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
485,5,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
486,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
486,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
486,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
486,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
486,5,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
487,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
487,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
487,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
487,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
487,5,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
488,1,Alpha haemolytic streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
488,2,Bacterial sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
488,3,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
488,4,Lymphodepletion,Haematological therapeutic procedures NEC,Haematological and lymphoid tissue therapeutic procedures,Surg,N
488,5,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
488,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
488,7,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
488,8,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
489,1,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
490,1,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
491,1,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
492,1,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
493,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
493,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
493,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
493,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
493,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
493,6,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
494,1,Foetal exposure timing unspecified,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
494,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
494,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
495,1,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
495,2,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
495,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
495,4,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,N
495,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
495,6,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
495,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
496,1,Acute graft versus host disease in intestine,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
496,2,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
496,3,Chronic graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
496,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
497,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,Y
498,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,Y
499,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
499,2,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
499,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
500,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
500,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
501,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
502,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
502,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
503,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
503,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
504,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
504,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
504,3,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
504,4,Glomerulonephritis membranous,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
504,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
504,6,Myelitis transverse,Myelitis (incl infective),Central nervous system infections and inflammations,Nerv,N
504,7,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
505,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
505,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
505,3,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
506,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
507,1,Chronic graft versus host disease in intestine,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
507,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
507,3,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
507,4,Malnutrition,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
507,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
507,6,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
508,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
508,2,Legionella infection,Legionella infections,Bacterial infectious disorders,Infec,N
508,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
508,4,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
508,5,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
508,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
509,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
509,2,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
510,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
510,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
510,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
511,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
511,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
511,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
511,4,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
512,1,Ewing's sarcoma,Bone sarcomas,Skeletal neoplasms malignant and unspecified,Neopl,N
512,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
513,1,B precursor type acute leukaemia,Leukaemias acute lymphocytic,Leukaemias,Neopl,Y
513,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
514,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
514,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
514,3,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
514,4,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
514,5,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
514,6,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
514,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
514,8,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
514,9,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
515,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
515,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
515,3,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
515,4,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
515,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
515,6,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
515,7,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
516,1,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
517,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
517,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
517,3,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
517,4,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
517,5,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
517,6,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
517,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
517,8,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
517,9,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
517,10,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
518,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
518,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
518,3,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
518,4,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
518,5,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
518,6,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
518,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
518,8,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
518,9,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
519,1,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
519,2,Streptococcal bacteraemia,Streptococcal infections,Bacterial infectious disorders,Infec,N
520,1,Enterobacter infection,Enterobacter infections,Bacterial infectious disorders,Infec,N
520,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
520,3,Gastroenteritis astroviral,Astroviral infections,Viral infectious disorders,Infec,N
521,1,Graft versus host disease in gastrointestinal tract,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
521,2,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
521,3,Leukaemia recurrent,Leukaemias NEC,Leukaemias,Neopl,N
522,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
522,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
522,3,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
523,1,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
523,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
523,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
524,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
524,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
525,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
525,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
525,3,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
525,4,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
526,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
526,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
526,3,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,Y
526,4,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
527,1,Activated partial thromboplastin time shortened,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
527,2,Aphthous ulcer,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
527,3,Apoptosis,Cell metabolism disorders NEC,Metabolism disorders NEC,Metab,N
527,4,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
527,5,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
527,6,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
527,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
527,8,Gastrointestinal wall thickening,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
527,9,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
527,10,Haematocrit decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
527,11,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
527,12,Prothrombin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
527,13,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
527,14,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
527,15,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
528,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
528,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
528,3,Graft versus host disease in gastrointestinal tract,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
528,4,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
528,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
529,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
529,2,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
530,1,Acute myeloid leukaemia recurrent,Leukaemias acute myeloid,Leukaemias,Neopl,Y
530,2,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
530,3,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
531,1,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
531,2,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
532,1,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
532,2,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
533,1,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
533,2,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
534,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
535,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
535,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
535,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
535,4,Pneumonia viral,Viral infections NEC,Viral infectious disorders,Infec,Y
536,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
536,2,Foetal exposure timing unspecified,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
536,3,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
536,4,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
537,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
537,2,Haemophilus infection,Haemophilus infections,Bacterial infectious disorders,Infec,N
537,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
537,4,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
537,5,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
537,6,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
537,7,Pneumonia adenoviral,Adenoviral infections,Viral infectious disorders,Infec,N
538,1,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
538,2,Dysbiosis,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
538,3,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
538,4,Graft versus host disease in gastrointestinal tract,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
538,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
539,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
539,2,Autoimmune neutropenia,Neutropenias,White blood cell disorders,Blood,N
539,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
539,4,Renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
540,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
540,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
541,1,B precursor type acute leukaemia,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
541,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
541,3,Philadelphia positive acute lymphocytic leukaemia,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
542,1,Acute myeloid leukaemia recurrent,Leukaemias acute myeloid,Leukaemias,Neopl,N
543,1,Acute lymphocytic leukaemia recurrent,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
544,1,Acute myeloid leukaemia recurrent,Leukaemias acute myeloid,Leukaemias,Neopl,N
545,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
546,1,Acute lymphocytic leukaemia recurrent,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
547,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
547,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
547,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
548,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
549,1,Acute lymphocytic leukaemia recurrent,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
550,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
550,2,Philadelphia positive acute lymphocytic leukaemia,Leukaemias acute lymphocytic,Leukaemias,Neopl,Y
551,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
552,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
552,2,Juvenile chronic myelomonocytic leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,Y
552,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
553,1,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
553,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
553,3,Renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
554,1,Actinic keratosis,Skin preneoplastic conditions NEC,Cornification and dystrophic skin disorders,Skin,N
554,2,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
554,3,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
554,4,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
554,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
554,6,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
554,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
555,1,Ewing's sarcoma,Bone sarcomas,Skeletal neoplasms malignant and unspecified,Neopl,N
555,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
556,1,Human herpesvirus 6 infection reactivation,Herpes viral infections,Viral infectious disorders,Infec,N
556,2,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
556,3,Mucoepidermoid carcinoma of salivary gland,Salivary gland neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
556,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
556,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
557,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
557,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
558,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
558,2,Embryonal rhabdomyosarcoma,Rhabdomyosarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
558,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
558,4,Varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
559,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
559,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
559,3,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
559,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
559,5,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
559,6,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
559,7,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
559,8,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
559,9,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
559,10,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
559,11,Streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
560,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
560,2,Autoimmune neutropenia,Neutropenias,White blood cell disorders,Blood,N
560,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
560,4,Renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
561,1,Human herpesvirus 6 infection reactivation,Herpes viral infections,Viral infectious disorders,Infec,N
561,2,Mucoepidermoid carcinoma of salivary gland,Salivary gland neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
561,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
562,1,Actinic keratosis,Skin preneoplastic conditions NEC,Cornification and dystrophic skin disorders,Skin,N
562,2,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
562,3,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
563,1,Behaviour disorder,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
563,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
563,3,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
563,4,Enterovirus infection,Enteroviral infections NEC,Viral infectious disorders,Infec,N
563,5,Meningoencephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
564,1,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
564,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
565,1,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
565,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
566,1,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
566,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
567,1,Renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
567,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
568,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
568,2,Autoimmune neutropenia,Neutropenias,White blood cell disorders,Blood,N
568,3,Infection reactivation,Infections NEC,Infections - pathogen unspecified,Infec,N
568,4,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
568,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
568,6,Renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
568,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
569,1,Human herpesvirus 6 infection reactivation,Herpes viral infections,Viral infectious disorders,Infec,N
569,2,Mucoepidermoid carcinoma of salivary gland,Salivary gland neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
569,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
570,1,Human herpesvirus 6 infection reactivation,Herpes viral infections,Viral infectious disorders,Infec,N
570,2,Mucoepidermoid carcinoma of salivary gland,Salivary gland neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
570,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
570,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
571,1,Appendicitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
572,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
572,2,Appendicitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
572,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
573,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
573,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
573,3,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,N
573,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
573,5,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
573,6,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
573,7,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
573,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
573,9,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
573,10,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
573,11,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
573,12,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
573,13,Vaccination site inflammation,Vaccination site reactions,Administration site reactions,Genrl,N
574,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
574,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
574,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
575,1,Evans syndrome,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
575,2,Glomerulonephritis membranous,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
575,3,Myelitis transverse,Myelitis (incl infective),Central nervous system infections and inflammations,Nerv,N
576,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
576,2,Atypical mycobacterial infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
576,3,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
576,4,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
576,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
576,6,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
576,7,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
576,8,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
576,9,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
577,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
577,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
577,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
577,4,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,Y
578,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
578,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
578,3,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
578,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
578,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
578,6,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
578,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
579,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
579,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
579,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
579,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
579,5,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
579,6,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
579,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
579,8,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
579,9,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
579,10,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
579,11,Still's disease,Rheumatoid arthropathies,Joint disorders,Musc,N
580,1,BK virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
580,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
580,3,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
580,4,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
580,5,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
580,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
580,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
580,8,Viraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
581,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
581,2,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
581,3,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
581,4,Human herpesvirus 6 infection,Herpes viral infections,Viral infectious disorders,Infec,N
581,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
581,6,Varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
582,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
582,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
582,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
582,4,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
582,5,Serratia infection,Serratia infections,Bacterial infectious disorders,Infec,N
583,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
583,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
583,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
583,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
584,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
584,2,BK virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
584,3,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
584,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
584,5,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
584,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
584,7,Viral haemorrhagic cystitis,Viral infections NEC,Viral infectious disorders,Infec,N
585,1,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
585,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
585,3,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
585,4,Serum amyloid A protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
586,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
586,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
586,3,Evans syndrome,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
586,4,Glomerulonephritis membranous,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
586,5,Myelitis transverse,Myelitis (incl infective),Central nervous system infections and inflammations,Nerv,N
586,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
587,1,Acute graft versus host disease in intestine,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
587,2,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
587,3,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
587,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
587,5,Fasciitis,Musculoskeletal and connective tissue infections and inflammations NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
587,6,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
587,7,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
587,8,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
587,9,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
588,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,Y
589,1,Blastic plasmacytoid dendritic cell neoplasia,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
589,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
589,3,Recurrent cancer,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
590,1,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
590,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
590,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
591,1,Inflammation,Inflammations,General system disorders NEC,Genrl,Y
591,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
591,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
592,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
592,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
593,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
593,2,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
594,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
595,1,Bronchiolitis,Viral infections NEC,Viral infectious disorders,Infec,N
595,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
595,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
595,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
596,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
596,2,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
597,1,Hypersensitivity pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
597,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
598,1,Candida pneumonia,Candida infections,Fungal infectious disorders,Infec,N
598,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
598,3,Pneumonia fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
598,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
599,1,Coombs negative haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
600,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
601,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
601,2,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
602,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
603,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
603,2,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
603,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
604,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
604,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
605,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
605,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
606,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
606,2,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
607,1,Altered state of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
607,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
607,3,Myelitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,Y
607,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
608,1,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
609,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
610,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
610,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
610,3,Dysdiadochokinesis,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
610,4,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
610,5,Extensor plantar response,Abnormal reflexes,Neurological disorders NEC,Nerv,N
610,6,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
610,7,Facial paresis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
610,8,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
610,9,Hypertonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
610,10,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
610,11,Past-pointing,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
610,12,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
610,13,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
611,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
612,1,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
612,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
613,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
613,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
613,3,Enterobacter bacteraemia,Enterobacter infections,Bacterial infectious disorders,Infec,N
613,4,Escherichia bacteraemia,Escherichia infections,Bacterial infectious disorders,Infec,N
613,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
613,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
613,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
614,1,Enterobacter bacteraemia,Enterobacter infections,Bacterial infectious disorders,Infec,N
614,2,Escherichia bacteraemia,Escherichia infections,Bacterial infectious disorders,Infec,N
615,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
615,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
616,1,Cystitis klebsiella,Klebsiella infections,Bacterial infectious disorders,Infec,N
616,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
617,1,Capillary leak syndrome,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
617,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
617,3,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
617,4,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
617,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
617,6,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
617,7,Hidradenitis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
617,8,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
617,9,Hypovolaemia,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
617,10,Oedema blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
617,11,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
617,12,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
617,13,Renal injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
617,14,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
617,15,Skin oedema,Skin vascular conditions NEC,Skin vascular abnormalities,Skin,N
617,16,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
617,17,Toxic erythema of chemotherapy,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
618,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
619,1,Capillary leak syndrome,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
619,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
619,3,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
619,4,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
619,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
619,6,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
619,7,Hidradenitis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
619,8,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
619,9,Hypovolaemia,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
619,10,Oedema blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
619,11,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
619,12,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
619,13,Renal injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
619,14,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
619,15,Skin oedema,Skin vascular conditions NEC,Skin vascular abnormalities,Skin,N
619,16,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
619,17,Toxic erythema of chemotherapy,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
620,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
621,1,Atypical mycobacterial infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
621,2,Leishmaniasis,Leishmania infections,Protozoal infectious disorders,Infec,N
621,3,Mucormycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
621,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
621,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
621,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
621,7,Syphilis,Treponema infections,Bacterial infectious disorders,Infec,N
621,8,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
622,1,Capillary leak syndrome,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
622,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
622,3,Toxic erythema of chemotherapy,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
623,1,Mycobacterium abscessus infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
623,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
623,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
623,4,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
623,5,Stenotrophomonas infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
624,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
624,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
624,3,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
625,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
625,2,Mycobacterium abscessus infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
625,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
625,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
626,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
626,2,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
626,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
626,4,Mycobacterium abscessus infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
626,5,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
626,6,Stenotrophomonas infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
626,7,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
627,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
627,2,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
627,3,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
627,4,Engraftment syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
627,5,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
627,6,Graft versus host disease in gastrointestinal tract,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
627,7,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
627,8,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
628,1,Cryptosporidiosis infection,Cryptosporidia infections,Protozoal infectious disorders,Infec,Y
628,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
628,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
628,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
629,1,Granuloma skin,Granulomatous and deep cutaneous inflammatory conditions,Epidermal and dermal conditions,Skin,N
629,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
629,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
629,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
629,5,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
630,1,Cryptosporidiosis infection,Cryptosporidia infections,Protozoal infectious disorders,Infec,N
630,2,Encephalitis cytomegalovirus,Cytomegaloviral infections,Viral infectious disorders,Infec,N
630,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
630,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
631,1,Encephalitis mumps,Mumps viral infections,Viral infectious disorders,Infec,Y
631,2,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
631,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
632,1,Granuloma skin,Granulomatous and deep cutaneous inflammatory conditions,Epidermal and dermal conditions,Skin,N
632,2,Immunodeficiency common variable,Primary immunodeficiency syndromes,Immunodeficiency syndromes,Immun,N
633,1,Mucormycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
634,1,Granuloma skin,Granulomatous and deep cutaneous inflammatory conditions,Epidermal and dermal conditions,Skin,N
634,2,Immunodeficiency common variable,Primary immunodeficiency syndromes,Immunodeficiency syndromes,Immun,N
635,1,Granuloma skin,Granulomatous and deep cutaneous inflammatory conditions,Epidermal and dermal conditions,Skin,N
635,2,Immunodeficiency common variable,Primary immunodeficiency syndromes,Immunodeficiency syndromes,Immun,N
636,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
636,2,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
636,3,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
637,1,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
637,2,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
637,3,Growth retardation,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
637,4,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
637,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
637,6,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
637,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
637,8,Viraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
638,1,Cryptosporidiosis infection,Cryptosporidia infections,Protozoal infectious disorders,Infec,N
638,2,Encephalitis cytomegalovirus,Cytomegaloviral infections,Viral infectious disorders,Infec,Y
638,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
638,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
639,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,Y
639,2,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
639,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
639,4,Parotitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
640,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
640,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
640,3,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
640,4,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
640,5,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
641,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
641,2,Herpes zoster meningoencephalitis,Herpes viral infections,Viral infectious disorders,Infec,N
641,3,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
641,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
641,5,Papilloma,Neoplasms benign site unspecified NEC,Miscellaneous and site unspecified neoplasms benign,Neopl,N
641,6,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
642,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
642,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
642,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
642,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
642,5,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
643,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
643,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
643,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
644,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
644,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
644,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
644,4,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
645,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
645,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
646,1,Chronic respiratory disease,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
646,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
646,3,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
646,4,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
646,5,Obliterative bronchiolitis,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
646,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
646,7,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
647,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
647,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
648,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
648,2,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
648,3,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
648,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
648,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
649,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
649,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
649,3,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
650,1,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
650,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
651,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
651,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
651,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
652,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
652,2,Toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,N
653,1,Cryptosporidiosis infection,Cryptosporidia infections,Protozoal infectious disorders,Infec,N
653,2,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
653,3,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
653,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
653,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
654,1,Mycobacterium abscessus infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
654,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
654,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
654,4,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
654,5,Stenotrophomonas infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
655,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
655,2,Gastrointestinal inflammation,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
655,3,Lack of spontaneous speech,Speech articulation and rhythm disturbances,Communication disorders and disturbances,Psych,N
655,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
655,5,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
655,6,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
655,7,Vascular device infection,Vascular infections,Infections - pathogen unspecified,Infec,N
655,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
656,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
656,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
656,3,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
656,4,Haemodynamic instability,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
656,5,Haemorrhagic ovarian cyst,Ovarian and fallopian tube cysts and neoplasms,Ovarian and fallopian tube disorders,Repro,N
656,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
656,7,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
657,1,Acute myeloid leukaemia recurrent,Leukaemias acute myeloid,Leukaemias,Neopl,Y
657,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
657,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
657,4,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
657,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
658,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
658,2,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
658,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
658,4,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
658,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
658,6,Pneumonia fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
658,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
658,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
659,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
659,2,Haemodynamic instability,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
659,3,Haemorrhagic ovarian cyst,Ovarian and fallopian tube cysts and neoplasms,Ovarian and fallopian tube disorders,Repro,N
659,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
660,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,Y
660,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
661,1,Acute graft versus host disease in intestine,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
661,2,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
662,1,Chronic lymphocytic leukaemia recurrent,Leukaemias chronic lymphocytic,Leukaemias,Neopl,N
663,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
663,2,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
664,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
665,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
665,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
665,3,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
665,4,Haemorrhagic ovarian cyst,Ovarian and fallopian tube cysts and neoplasms,Ovarian and fallopian tube disorders,Repro,N
665,5,Ovarian cyst ruptured,Ovarian and fallopian tube cysts and neoplasms,Ovarian and fallopian tube disorders,Repro,N
665,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
666,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,Y
666,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
667,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
667,2,Parainfluenzae virus infection,Parainfluenzae viral infections,Viral infectious disorders,Infec,Y
668,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
668,2,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,Y
669,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
669,2,Polyomavirus viraemia,Polyomavirus infections,Viral infectious disorders,Infec,N
670,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
670,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
670,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
671,1,Mycobacterium kansasii infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
671,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
672,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
672,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
672,3,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,N
672,4,Rotavirus infection,Rotaviral infections,Viral infectious disorders,Infec,N
672,5,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
672,6,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
673,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
673,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
673,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
674,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
674,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
674,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
674,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
675,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
675,2,Encephalomyelitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,Y
676,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
676,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
677,1,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
677,2,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
677,3,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
677,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
677,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
678,1,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
678,2,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
678,3,Polyomavirus viraemia,Polyomavirus infections,Viral infectious disorders,Infec,N
679,1,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
679,2,Mycobacterium kansasii infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
679,3,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
679,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
679,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
680,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
680,2,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
680,3,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
680,4,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
680,5,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
680,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
681,1,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
681,2,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
681,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
681,4,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
681,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
682,1,Human herpesvirus 6 infection,Herpes viral infections,Viral infectious disorders,Infec,N
682,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
683,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
683,2,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
683,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
683,4,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
684,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
684,2,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
684,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
684,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
684,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
685,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
685,2,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,N
685,3,Rotavirus infection,Rotaviral infections,Viral infectious disorders,Infec,N
685,4,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
686,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
686,2,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
686,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
687,1,Human herpesvirus 6 infection,Herpes viral infections,Viral infectious disorders,Infec,N
687,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
688,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
688,2,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
688,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
689,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
689,2,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
689,3,Micrococcal sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
689,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
690,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
690,2,Capillary leak syndrome,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
690,3,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
690,4,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
690,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
690,6,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,Y
690,7,Viraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
691,1,Capillary leak syndrome,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
691,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
691,3,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
691,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
691,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
692,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
692,2,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
692,3,Early satiety,Feelings and sensations NEC,General system disorders NEC,Genrl,N
692,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
692,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
692,6,Graft versus host disease in gastrointestinal tract,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
692,7,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
692,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
692,9,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
692,10,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
692,11,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
692,12,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
692,13,Pleurisy,Pleural infections and inflammations,Pleural disorders,Resp,N
692,14,Serositis,Inflammations,General system disorders NEC,Genrl,N
692,15,Thyroiditis,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
693,1,Autoimmune pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
693,2,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
693,3,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
693,4,Large granular lymphocytosis,Leukaemias chronic T-cell,Leukaemias,Neopl,N
693,5,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
693,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
693,7,Pure white cell aplasia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
694,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
694,2,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
694,3,Autoimmune pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
694,4,BK virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
694,5,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
694,6,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
694,7,Large granular lymphocytosis,Leukaemias chronic T-cell,Leukaemias,Neopl,N
694,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
695,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
695,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
695,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
695,4,Tumour haemorrhage,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,Y
696,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
697,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
697,2,Periorbital cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
698,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
698,2,Blindness cortical,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
698,3,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
698,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
698,5,Toxic leukoencephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
699,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
700,1,Catatonia,Decreased physical activity levels,Changes in physical activity,Psych,N
700,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
700,3,Communication disorder,Communications disorders,Communication disorders and disturbances,Psych,N
700,4,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
700,5,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
700,6,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
700,7,Social avoidant behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
701,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
701,2,Neurological decompensation,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
701,3,Toxic leukoencephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,Y
702,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
702,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
702,3,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
703,1,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,Y
703,2,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
704,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
704,2,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
705,1,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,Y
706,1,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
707,1,Atrial flutter,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
707,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
707,3,Escherichia bacteraemia,Escherichia infections,Bacterial infectious disorders,Infec,N
707,4,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
707,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
708,1,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
709,1,Myelitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
709,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
709,3,Paraplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
709,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
710,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
710,2,Graft versus host disease in gastrointestinal tract,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
711,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
711,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
711,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
712,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
712,2,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
713,1,Pseudostroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
714,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
715,1,Clavicle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
715,2,Clavicle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
715,3,Femur fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
715,4,Fibula fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
715,5,Fibula fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
715,6,Foot fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
715,7,Humerus fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
715,8,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
715,9,Nephrocalcinosis,Renal lithiasis,Urolithiases,Renal,N
715,10,Pathological fracture,Fractures NEC,Fractures,Musc,N
715,11,Tibia fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
715,12,Tibia fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
716,1,Capillary leak syndrome,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
716,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
716,3,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
716,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
716,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
716,6,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
716,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
717,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
718,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
718,2,Capillary leak syndrome,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
718,3,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
718,4,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
718,5,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
718,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
718,7,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
718,8,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
718,9,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
718,10,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
718,11,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
718,12,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,Y
718,13,Viraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
719,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
719,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
719,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
719,4,Dysgraphia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
719,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
719,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
719,7,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
719,8,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
719,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
719,10,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
720,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
721,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
722,1,Actinic keratosis,Skin preneoplastic conditions NEC,Cornification and dystrophic skin disorders,Skin,N
722,2,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
722,3,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
722,4,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
722,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
722,6,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
722,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
723,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
723,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
723,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
723,4,Dysgraphia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
723,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
723,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
723,7,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
723,8,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
723,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
723,10,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
724,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
724,2,H1N1 influenza,Influenza viral infections,Viral infectious disorders,Infec,N
724,3,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
724,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
724,5,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
724,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
724,7,Pneumonia bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
724,8,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
724,9,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
725,1,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
725,2,Pericardial disease,Pericardial disorders NEC,Pericardial disorders,Card,N
726,1,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
726,2,Pericarditis constrictive,Noninfectious pericarditis,Pericardial disorders,Card,N
727,1,Acute myeloid leukaemia recurrent,Leukaemias acute myeloid,Leukaemias,Neopl,Y
727,2,Adenovirus reactivation,Adenoviral infections,Viral infectious disorders,Infec,N
727,3,Leukaemic infiltration pulmonary,Leukaemias NEC,Leukaemias,Neopl,N
727,4,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
727,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
728,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
728,2,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
729,1,Acute myeloid leukaemia recurrent,Leukaemias acute myeloid,Leukaemias,Neopl,N
729,2,Acute myeloid leukaemia refractory,Leukaemias acute myeloid,Leukaemias,Neopl,N
729,3,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
729,4,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
729,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
729,6,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
730,1,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
730,2,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
731,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,Y
732,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
732,2,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
733,1,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,Y
734,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
735,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
735,2,Pharyngeal inflammation,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
735,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
735,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
736,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
737,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
737,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
737,3,Pneumonia viral,Viral infections NEC,Viral infectious disorders,Infec,N
737,4,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
737,5,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,Y
738,1,Bacterial sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
738,2,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
738,3,Fungaemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
738,4,Pneumonia fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
738,5,Raoultella ornithinolytica infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
739,1,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,Y
740,1,Fungaemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
741,1,Adenovirus reactivation,Adenoviral infections,Viral infectious disorders,Infec,N
741,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
742,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
742,2,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
742,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
742,4,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
743,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
744,1,Delayed puberty,Endocrine abnormalities of puberty,Endocrine disorders of gonadal function,Endo,N
745,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,Y
746,1,Delayed puberty,Endocrine abnormalities of puberty,Endocrine disorders of gonadal function,Endo,N
747,1,Hepatic lesion,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
747,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
747,3,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
747,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
747,5,Splenic lesion,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
748,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
748,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
748,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
748,4,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
748,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
749,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
749,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
749,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
749,4,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
750,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
750,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
750,3,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
750,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
750,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
750,6,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
751,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
751,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
751,3,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
751,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
752,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
752,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
752,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
752,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
752,5,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
752,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
753,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
753,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
753,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
753,4,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
753,5,Small intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
754,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
754,2,Hepatic lesion,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
754,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
754,4,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
755,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
755,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
755,3,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
755,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
755,5,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
755,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
756,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
756,2,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
756,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
757,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
757,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
757,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
757,4,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
757,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
758,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
758,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
758,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
758,4,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
758,5,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
759,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
759,2,Headache,Headaches NEC,Headaches,Nerv,N
759,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
759,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
759,5,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
759,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
760,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
760,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
760,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
760,4,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
760,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
761,1,Odynophagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
761,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
761,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
761,4,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
762,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
762,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
762,3,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
763,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
763,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
763,3,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
764,1,Autoimmune neutropenia,Neutropenias,White blood cell disorders,Blood,N
764,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
765,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
766,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
766,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
766,3,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
766,4,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
766,5,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
766,6,Angiopathy,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
766,7,Appendicitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
766,8,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
766,9,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
766,10,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
766,11,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
766,12,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
766,13,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
766,14,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
766,15,Chronic myeloid leukaemia recurrent,Leukaemias chronic myeloid,Leukaemias,Neopl,N
766,16,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
766,17,Connective tissue disorder,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
766,18,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
766,19,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
766,20,Death,Death and sudden death,Fatal outcomes,Genrl,Y
766,21,Dental caries,Dental and periodontal infections and inflammations,Dental and gingival conditions,Gastr,N
766,22,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
766,23,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
766,24,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
766,25,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
766,26,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
766,27,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
766,28,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
766,29,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
766,30,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
766,31,Headache,Headaches NEC,Headaches,Nerv,N
766,32,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
766,33,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
766,34,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
766,35,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
766,36,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
766,37,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
766,38,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
766,39,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
766,40,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
766,41,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
766,42,Infestation,Ectoparasitic infestations,Ectoparasitic disorders,Infec,N
766,43,Investigation abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
766,44,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
766,45,Leukocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
766,46,Lymphatic disorder,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
766,47,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
766,48,Malnutrition,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
766,49,Mediastinal disorder,Mediastinal disorders,Thoracic disorders (excl lung and pleura),Resp,N
766,50,Metabolic disorder,Metabolic disorders NEC,Metabolism disorders NEC,Metab,N
766,51,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
766,52,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
766,53,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
766,54,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
766,55,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
766,56,Non-cardiac chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
766,57,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
766,58,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
766,59,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
766,60,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
766,61,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
766,62,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
766,63,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
766,64,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
766,65,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
766,66,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
766,67,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
766,68,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
766,69,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
766,70,Transplantation complication,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
766,71,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
766,72,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
766,73,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
767,1,Non-cardiac chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
768,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
769,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
769,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
769,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
770,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
770,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
771,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
772,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
772,2,Klebsiella infection,Klebsiella infections,Bacterial infectious disorders,Infec,N
772,3,Klebsiella sepsis,Klebsiella infections,Bacterial infectious disorders,Infec,N
773,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
774,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
774,2,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
774,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
774,4,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
774,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
774,6,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
775,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
775,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
775,3,Oesophageal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
775,4,Oesophageal motility disorder,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
775,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
776,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
777,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
778,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
779,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
779,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
779,3,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
780,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
781,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
781,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
781,3,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
781,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
781,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
782,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
782,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
783,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
783,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
783,3,Diarrhoea infectious,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
783,4,Enterobacter bacteraemia,Enterobacter infections,Bacterial infectious disorders,Infec,N
783,5,Escherichia bacteraemia,Escherichia infections,Bacterial infectious disorders,Infec,N
783,6,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
783,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
783,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
784,1,Tooth infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
785,1,Tooth infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
786,1,Graft versus host disease in gastrointestinal tract,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
787,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
788,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
788,2,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
788,3,Rhinovirus infection,Rhinoviral infections,Viral infectious disorders,Infec,N
789,1,BK virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
789,2,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
789,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
789,4,Escherichia sepsis,Escherichia infections,Bacterial infectious disorders,Infec,N
789,5,Human herpesvirus 6 encephalitis,Herpes viral infections,Viral infectious disorders,Infec,N
789,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
789,7,Rhinovirus infection,Rhinoviral infections,Viral infectious disorders,Infec,N
790,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
790,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
791,1,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
792,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
793,1,Herpes virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
794,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
794,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
794,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
795,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
795,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
796,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
796,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
797,1,Acute myeloid leukaemia recurrent,Leukaemias acute myeloid,Leukaemias,Neopl,N
797,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
797,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
798,1,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
799,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
800,1,Congenital aplasia,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
800,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
800,3,Human herpesvirus 6 infection,Herpes viral infections,Viral infectious disorders,Infec,N
801,1,Human herpesvirus 6 infection,Herpes viral infections,Viral infectious disorders,Infec,N
801,2,Parvovirus infection,Parvoviral infections,Viral infectious disorders,Infec,N
802,1,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
802,2,Human herpesvirus 6 infection,Herpes viral infections,Viral infectious disorders,Infec,N
802,3,Parvovirus infection,Parvoviral infections,Viral infectious disorders,Infec,N
803,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
804,1,Parvovirus infection,Parvoviral infections,Viral infectious disorders,Infec,N
805,1,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
805,2,Human herpesvirus 6 infection,Herpes viral infections,Viral infectious disorders,Infec,N
805,3,Parvovirus infection,Parvoviral infections,Viral infectious disorders,Infec,N
806,1,Human herpesvirus 6 infection,Herpes viral infections,Viral infectious disorders,Infec,N
807,1,Human herpesvirus 8 infection,Herpes viral infections,Viral infectious disorders,Infec,N
807,2,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
808,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
808,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
809,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
809,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
809,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
810,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
811,1,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
812,1,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
812,2,Human herpesvirus 8 infection,Herpes viral infections,Viral infectious disorders,Infec,N
812,3,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
813,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
813,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
813,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
814,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
814,2,Human herpesvirus 8 infection,Herpes viral infections,Viral infectious disorders,Infec,N
814,3,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
815,1,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
816,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
816,2,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
816,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
816,4,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
816,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
817,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
817,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
817,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
817,4,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
818,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
818,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
819,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
819,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
819,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
820,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
820,2,Human herpesvirus 8 infection,Herpes viral infections,Viral infectious disorders,Infec,N
820,3,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
821,1,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
822,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
822,2,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
822,3,BK virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
822,4,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
822,5,Candida sepsis,Candida infections,Fungal infectious disorders,Infec,N
822,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
822,7,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
822,8,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
822,9,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
822,10,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
822,11,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
822,12,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
822,13,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
822,14,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
822,15,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
822,16,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
823,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
823,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
823,3,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
824,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
824,2,BK virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
824,3,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
824,4,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
824,5,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
824,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
824,7,Enterococcal bacteraemia,Enterococcal infections,Bacterial infectious disorders,Infec,N
824,8,Escherichia bacteraemia,Escherichia infections,Bacterial infectious disorders,Infec,N
824,9,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
824,10,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
824,11,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
824,12,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
824,13,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
824,14,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
824,15,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
824,16,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
824,17,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
824,18,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
824,19,Viral haemorrhagic cystitis,Viral infections NEC,Viral infectious disorders,Infec,N
825,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
825,2,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
825,3,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
825,4,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
825,5,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
826,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
827,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
827,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
